The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy
Completed Not Applicable NCT03704727
Study Description
The aim of this study is to test the hypothesis that adjuvant administration of probiotics in cancer patients undergoing chemotherapy can reduce a chemo-induced increased intestinal permeability. Furthermore, we hypothesize that the use of probiotics may reduce the occurrence of gastrointestinal side effects such as diarrhea, abdominal pains, bacterial translocation and infections following chemotherapy.
Study Details
- Registry ID:
- NCT03704727
- Conditions:
- Intestinal Permeability, Gastrointestinal Irritation, Mucositis
- Phase:
- Not Applicable
- Target Enrollment:
- 5 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Departmen of Oncology, Rigshospital
Copenhagen, Denmark
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.